A new tool for estimating liver cancer risk after a hepatitis C virus cure
- PMID: 33299837
- PMCID: PMC7720061
- DOI: 10.21037/hbsn.2020.03.08
A new tool for estimating liver cancer risk after a hepatitis C virus cure
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/hbsn.2020.03.08). The authors have no conflicts of interest to declare.
Comment on
-
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals.J Hepatol. 2020 Mar;72(3):472-480. doi: 10.1016/j.jhep.2019.10.005. Epub 2019 Oct 17. J Hepatol. 2020. PMID: 31629779
References
-
- GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1459-544. 10.1016/S0140-6736(16)31012-1 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources